- This event has passed.
Covid Testing in a Vaccinated Population: Needed or Obsolete?
May 26, 2021 @ 10:00 am - 11:00 am PDT
While the number of fully vaccinated people in the U.S. continues to rise and infection numbers remain relatively low, demand for testing has decreased. Schools and many businesses, however, have implemented testing procedures to accelerate a return to campuses and offices. Germany just mandated employers to offer free testing.
Will testing remain an essential tool in the fight against the pandemic, especially as new strains evolve around the Globe? What level of testing is useful to help avoid new waves of infections? Can tests help us monitor for new variants? Should vaccinated people participate in regular testing or be excluded? What are best practices in testing and what kinds of tests are best for different contexts?
We will address these and other questions and discuss whether businesses, educational institutions and cultural organizations consider testing vital to stay open or to bring employees, students or customers back into their buildings. This interactive panel discussion brings together scientists, experts and representatives from all sides of this issue.
This is the third collaboration in our transatlantic webinar series on the Covid pandemic between the German Consulates in Boston and San Francisco as well as the GABC Boston and GABA Northern California.
Head Of School at German International School of Silicon Valley
More speakers to be announced soon
President & CEO, Biolabs
President & Executive Director, LabCentral
In cooperation with the German American Business Council, Boston, the German Consulates of Boston and San Francisco
FREE but registration is required
By taking part in this event you grant the event organizers and partners full rights to use the images resulting from the photography/video filming, and any reproductions or adaptations of the images for fundraising, publicity or other purposes to help achieve the association's aims. This might include (but is not limited to), the right to use them in their printed and online publicity, social media, press releases and funding applications. Please contact us with any questions.